Emma R. Parmee, Simon V. Mortlock, Nicholas A. Stacey, Eric J. Thomas and (the late) Owen S. Mills
Dehydration of the 5-hydroxycyclohexanecarboxylate 13 gives the
exocyclic alkene 14 rather than its endocyclic isomer. However, the
3,4-double bond can be introduced into precursors of milbemycin E 1
using oxidative elimination of phenylselanyl ketones. The
hydroxycyclohexanones 6 and 31 have been converted into the
phenylselanyl ketones 19 and 37, which on oxidative elimination followed
by stereoselective reduction give the 3-methylcyclohex-2-enecarboxylates
23 and 40 together with only 10–15% of the exocyclic alkenes 24
and 42. Interestingly, if the oxidative elimination is carried out on
the alcohol 25, the 5-methylenecyclohexanecarboxylate 24 is the major
product. Conversion of 40 into its benzoate, and oxidation of the furan
ring using singlet oxygen, gives the hydroxybutenolide 43 ready for
incorporation into a milbemycin synthesis. To test the compatibilty of
the cyclohexene double bond with the proposed Wittig reaction, the
alcohol 40 has been converted into the tert-butyldimethylsilyl
ether 44 and the furan oxidised to give the hydroxybutenolide 45.
Condensation with an excess of (2-methylpropylidene)triphenylphosphorane
gives the Wittig product which has been isolated as its methyl ester and
isomerised using a trace of iodine into the
(Z,E)-diene 47.